1. Impact of Coronavirus Disease 2019 Restrictions on Retinal Detachment: A Multicenter Experience
- Author
-
Jung, Jesse J., Chang, Jonathan S., Oellers, Patrick R., Ali, Mohsin H., Do, Brian K., Tseng, Joseph J., Roizenblatt, Roberto, Muni, Rajeev H., Weng, Christina Y., Oakey, Zackery B., Tsao, Sean W., Rofagha, Soraya, Chan, Xavier, Hoang, Quan V., Russ Richardson, Daniel, Toledo-Corral, Jaime, Pandya, Hemang K., Copeland, Victor T., Jonna, Gowtham, Zahid, Sarwar, Lin, James, Thanos, Aristomenis, Ezon, Isaac, Movahedan, Asadolah, Schechet, Sidney A., Mehta, Mitul C., Hamli, Hesham, Puri, Sidharth, Jhaveri, Chirag D., Ridgeley, Jamison R., Sheyman, Alan T., Hu, Jonathan, Lu, Stephanie Y., Browne, Andrew W., Huang, Lynn L., Chee, Yewlin E., Elmann, Solly, Chaudhary, Khurram M., Mehta, Nitish, Kurochkin, Philip, Gjyzeli, Genti, Altaweel, Michael M., Michael Nork, T., Zeng, Anne, Loh, Isabella Q., and Yi Lin, Hong
- Abstract
In this retrospective, multicenter study of 261 eyes (259 patients), patients who underwent rhegmatogenous retinal detachment repair during the coronavirus disease 2019 (COVID-19) post-lockdown period experienced an additional 22-day delay, leading to significantly more epiretinal membrane and proliferative vitreoretinopathy and lower single-surgery anatomic success rates. During lockdown, perfluoropropane gas was used more commonly, and pneumatic retinopexy was used more commonly in COVID-19–positive patients.
- Published
- 2022
- Full Text
- View/download PDF